Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tanja D de Gruijl"'
Autor:
Kamran Nazmi, Tanja D. de Gruijl, Gert Storm, Medha D. Joshi, Erik Hooijberg, Jan G. M. Bolscher, Yvette van Kooyk, Martino Ambrosini, Wendy W. J. Unger, Sven C. M. Bruijns, Hakan Kalay, Astrid J. van Beelen, Marleen I. Verstege, Louis van Bloois, Cynthia M. Fehres
Publikováno v:
Journal of Controlled Release, 160(1), 88-95. Elsevier
Unger, W W J, van Beelen, A J, Bruijns, S C M, Joshi, M, Fehres, C M, van Bloois, L, Verstege, M I, Ambrosini, M, Kalay, H, Nazmi, K, Bolscher, J G, Hooijberg, E, de Gruijl, T D, Storm, G & van Kooyk, Y 2012, ' Glycan-modified liposomes boost CD4(+) and CD8(+) T-cell responses by targeting DC-SIGN on dendritic cells ', Journal of Controlled Release, vol. 160, no. 1, pp. 88-95 . https://doi.org/10.1016/j.jconrel.2012.02.007
Unger, W W J, van Beelen, A J, Bruijns, S C, Joshi, M, Fehres, C M, van Bloois, L, Verstege, M I, Ambrosini, M, Kalay, H, Nazmi, K, Bolscher, J G, Hooiberg, E, de Gruijl, T D, Storm, G & van Kooyk, Y 2012, ' Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells ', Journal of Controlled Release, vol. 160, no. 1, pp. 88-95 . https://doi.org/10.1016/j.jconrel.2012.02.007
Unger, W W J, van Beelen, A J, Bruijns, S C M, Joshi, M, Fehres, C M, van Bloois, L, Verstege, M I, Ambrosini, M, Kalay, H, Nazmi, K, Bolscher, J G, Hooijberg, E, de Gruijl, T D, Storm, G & van Kooyk, Y 2012, ' Glycan-modified liposomes boost CD4(+) and CD8(+) T-cell responses by targeting DC-SIGN on dendritic cells ', Journal of Controlled Release, vol. 160, no. 1, pp. 88-95 . https://doi.org/10.1016/j.jconrel.2012.02.007
Unger, W W J, van Beelen, A J, Bruijns, S C, Joshi, M, Fehres, C M, van Bloois, L, Verstege, M I, Ambrosini, M, Kalay, H, Nazmi, K, Bolscher, J G, Hooiberg, E, de Gruijl, T D, Storm, G & van Kooyk, Y 2012, ' Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells ', Journal of Controlled Release, vol. 160, no. 1, pp. 88-95 . https://doi.org/10.1016/j.jconrel.2012.02.007
Cancer immunotherapy requires potent tumor-specific CD8(+) and CD4(+) T-cell responses, initiated by dendritic cells (DCs). Tumor antigens can be specifically targeted to DCs in vivo by exploiting their expression of C-type lectin receptors (CLR), wh
Autor:
Rieneke van de Ven, Tanja D. de Gruijl
Progress in vector design and an increased knowledge of mechanisms underlying tumor-induced immune suppression have led to a new and promising generation of Adenovirus (Ad)-based immunotherapies, which are discussed in this review. As vaccine vehicle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87800483e242963f27925f0ce0b7cd01
https://doi.org/10.1016/b978-0-12-398342-8.00006-9
https://doi.org/10.1016/b978-0-12-398342-8.00006-9
Autor:
Amanda A. van Vliet, Ella Peters, Denise Vodegel, Daniëlle Steenmans, Monica Raimo, Susan Gibbs, Tanja D. de Gruijl, Adil D. Duru, Jan Spanholtz, Anna-Maria Georgoudaki
Publikováno v:
iScience, Vol 26, Iss 7, Pp 107078- (2023)
Summary: Umbilical cord blood (UCB) CD34+ progenitor cell-derived natural killer (NK) cells exert efficient cytotoxicity against various melanoma cell lines. Of interest, the relative cytotoxic performance of individual UCB donors was consistent thro
Externí odkaz:
https://doaj.org/article/d1425338c1d4414a97480c3edb937771
Autor:
Dorian A. Stolk, Sophie K. Horrevorts, Sjoerd T.T. Schetters, Laura J.W. Kruijssen, Sanne Duinkerken, Eelco Keuning, Martino Ambrosini, Hakan Kalay, Rieneke van de Ven, Juan J. Garcia-Vallejo, Tanja D. de Gruijl, Sandra J. van Vliet, Yvette van Kooyk
Publikováno v:
Molecular Therapy: Oncolytics, Vol 21, Iss , Pp 315-328 (2021)
Induction of tumor-specific cytotoxic CD8+ T cells (CTLs) via immunization relies on the presentation of tumor-associated peptides in major histocompatibility complex (MHC) class I molecules by dendritic cells (DCs). To achieve presentation of exogen
Externí odkaz:
https://doaj.org/article/2ff62c35b69d455394582a46f07cde98
Autor:
Tereza Brachtlova, Jan-Willem van Ginkel, Mark J. Luinenburg, Renée X. de Menezes, Danijela Koppers-Lalic, D. Michiel Pegtel, Wenliang Dong, Tanja D. de Gruijl, Victor W. van Beusechem
Publikováno v:
Molecular Therapy: Oncolytics, Vol 19, Iss , Pp 332-343 (2020)
Oncolytic adenoviruses are being developed as new anti-cancer agents. Their efficacy can be improved by incorporating RNA interference (RNAi) molecules. RNAi molecules can be expressed in various precursor formats. The aim of this study was to determ
Externí odkaz:
https://doaj.org/article/1aaae3dbac784368bbd487059385b756